Evidence map›Paper›PMID 40556129›Full record

ArticleCell transplantation

Optimizing GBM organoid construction with hydrogel-based models: GelMA-HAMA scaffold supports GBM organoids with clonal growth for drug screening.

Min Zhou, Ke Yue, Jingjing Zhao, Shuhua Gong, Yutong Xie, Wenyu Wu, Zhenzhou Li, Shuo Wu, Zhengliang Gao, Huan Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Min ZhouShanghai Baoshan Luodian Hospital, School of Medicine, Shanghai University, Shanghai, China.ORCID 0000-0001-5243-452X
Ke YueShanghai Baoshan Luodian Hospital, School of Medicine, Shanghai University, Shanghai, China.
Jingjing ZhaoShanghai Baoshan Luodian Hospital, School of Medicine, Shanghai University, Shanghai, China.
Shuhua GongShanghai Baoshan Luodian Hospital, School of Medicine, Shanghai University, Shanghai, China.
Yutong XieDepartment of Otolaryngology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Wenyu WuShanghai Baoshan Luodian Hospital, School of Medicine, Shanghai University, Shanghai, China.
Zhenzhou LiDepartment of Anesthesiology and Perioperative Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.
Shuo WuShanghai Baoshan Luodian Hospital, School of Medicine, Shanghai University, Shanghai, China.
Zhengliang GaoShanghai Baoshan Luodian Hospital, School of Medicine, Shanghai University, Shanghai, China.
Huan WangDepartment of Anesthesiology, Shanghai Pudong New Area Gongli Hospital, Shanghai, China.
Jianrong GuoDepartment of Anesthesiology, Shanghai Pudong New Area Gongli Hospital, Shanghai, China.ORCID 0000-0002-1855-1762

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult glioblastoma (GBM) is a highly malignant tumor with a poor prognosis and high mortality rate. As versatile 3D culture systems

Indexed as

Brain NeoplasmsGlioblastomaHydrogelsOrganoidsTissue ScaffoldsCell ProliferationCollagenDrug CombinationsDrug Evaluation, PreclinicalGelatinHumansHyaluronic AcidLamininProteoglycansCollagenDrug CombinationsGelatinHyaluronic AcidHydrogelsLamininmatrigelProteoglycansCSMAdrug testingGelMAglioblastoma organoidsHAMAhydrogelMatrigel

Identifiers

PMID40556129
PMCPMC12188089

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.